Navigation Links
LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
Date:1/12/2012

CINCINNATI, Jan. 12, 2012 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that management will present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012, at 3:00 p.m. Eastern time.  A live and archived webcast of the presentation will be available at the Investor Relations section of LCA-Vision's website at www.lasikplus.com.
The conference is being held at the Hard Rock Hotel in Hollywood, Fla.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment; Transforming Lives Every Day.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

LHA513-792-9292

310-691-7100


'/>"/>

SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. LCA-Vision Names Michael J. Celebrezze CFO
3. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
4. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
5. NW Bio to Present Today at the OneMedForum SF 2012 Conference
6. Chembio Presenting at Biotech Conference
7. 3SBio Inc. to Present at the UBS Greater China Conference 2012
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
10. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
11. InterMune to Present at J. P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and ... they have entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas ... tools for gene editing across all applications. , Under the terms of the ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving air ... living in larger cities are affected by air pollution related diseases. , That is ... globally - decided to take action. , “I knew I had to take action ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):